CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,157 | -12.9% | 2,731 | +7.4% | 0.00% | 0.0% |
Q2 2023 | $86,284 | -5.7% | 2,543 | 0.0% | 0.00% | -20.0% |
Q1 2023 | $91,497 | -27.5% | 2,543 | -10.2% | 0.01% | -16.7% |
Q4 2022 | $126,267 | +49.9% | 2,833 | -5.4% | 0.01% | +50.0% |
Q3 2022 | $84,218 | +4.3% | 2,996 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $80,772 | -20.8% | 2,996 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $102,044 | -78.3% | 2,996 | -75.3% | 0.00% | -33.3% |
Q4 2021 | $469,399 | -28.4% | 12,148 | 0.0% | 0.01% | -40.0% |
Q3 2021 | $655,871 | +76.6% | 12,148 | +9.4% | 0.01% | +100.0% |
Q2 2021 | $371,418 | – | 11,107 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |